Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.

We know diet and exercise matter—but what about medications for prevention? Credit available for this activity expires: 5/20/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/episode-4-beyond-lifestyle-managing-cardiovascular-risk-2026a1000fuk?ecd=bdc_podcast_libsyn_mscpedu

Tackle high-risk early breast cancer (EBC) challenges with confidence and better patient engagement. Credit available for this activity expires: 5/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/sharing-decision-treatment-planning-high-risk-hr-her2-early-2026a1000f67?ecd=bdc_podcast_libsyn_mscpedu

See what risk scores miss and apply imaging to guide real-world decisions. Credit available for this activity expires: 05/15/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/personalizing-risk-assessment-enhance-cardiovascular-2026a1000evy?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on the latest noninvasive screening tools for MASH fibrosis? Credit available for this activity expires: 5/13/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/noninvasive-assessment-mash-fibrosis-2026a1000f5l?ecd=bdc_podcast_libsyn_mscpedu

Do you know how metabolic dysfunction and obesity impact liver health in your patients, and which therapies are in the pipeline for treating obesity-related liver disease? Credit available for this activity expires: 5/11/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/rapid-fire-your-questions-obesity-and-liver-disease-answered-2026a1000efi?ecd=bdc_podcast_libsyn_mscpedu

What do patients want to know about biosimilars? Credit available for this activity expires: 5/13/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003363?ecd=bdc_podcast_libsyn_mscpedu

How can automated insulin delivery systems help improve the management of your patients with type 2 diabetes? Hear our expert faculty discuss. Credit available for this activity expires: 5/8/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/ask-experts-best-practices-using-aid-achieve-outcomes-faster-2026a1000efj?ecd=bdc_podcast_libsyn_mscpedu

Your arteries may be older than you are--here's how we find out. Credit available for this activity expires: 5/8/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/episode-3-carotid-ultrasound-seeing-vascular-age-2026a1000een?ecd=bdc_podcast_libsyn_mscpedu

Could neoadjuvant immunotherapy be considered part of the standard of care for patients with mismatch repair deficient (dMMR) colon cancer? Credit available for this activity expires: 5/1/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/practical-community-colorectal-cancer-clinic-aligning-2026a1000dw7?ecd=bdc_podcast_libsyn_mscpedu

Do you know when to advance patients with IBS-C from over-the-counter to prescription treatments? Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/empowering-frontline-care-ibs-c-moving-beyond-otc-therapies-2026a1000cxp?ecd=bdc_podcast_libsyn_mscpedu

Optimize patient outcomes by selecting the right inhaler device for the right patient. Credit available for this activity expires: 4/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/right-fit-personalizing-copd-device-selection-across-patient-2026a1000dcc?ecd=bdc_podcast_libsyn_mscpedu

Next steps for major depressive disorder (MDD): master the latest clinical data on augmentation and switching strategies. Credit available for this activity expires: 4/29/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/when-monotherapy-fails-depression-evidence-based-update-2026a1000d6q?ecd=bdc_podcast_libsyn_mscpedu

Dr Brian Lacy discussed the management of constipation-predominant irritable bowel syndrome (IBS-C) in the context of patient cases. Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/symptoms-success-real-world-cases-patient-centered-ibs-c-2026a1000cze?ecd=bdc_podcast_libsyn_mscpedu

Experts discuss the different roles of clinicians in managing metabolic dysfunction-associated steatohepatitis (MASH). Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/multidisciplinary-management-metabolic-dysfunction-2026a1000d62?ecd=bdc_podcast_libsyn_mscpedu

Do you know how to apply best practices for HER2 testing and identify patients who may benefit from targeted therapies? Join us to learn more! Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-care-her2-mutated-nsclc-evidence-diagnostics-and-2026a1000d6g?ecd=bdc_podcast_libsyn_mscpedu

Explore how rapid-acting therapies transform major depressive disorder (MDD) care--uncover the neurobiology and mechanisms driving faster antidepressant effects. Credit available for this activity expires: [04/27/27] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/mechanisms-behind-rapid-acting-treatments-major-depressive-2026a1000cld?ecd=bdc_podcast_libsyn_mscpedu

How do you turn your patients' calcium scores into clear, personalized prevention plans? Credit available for this activity expires: 4/28/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/episode-two-cracking-code-coronary-artery-calcium-cac-2026a1000clt?ecd=bdc_podcast_libsyn_mscpedu

Master assessing high-risk hormone receptor (HR)-positive/HER2-negative early breast cancer (EBC): outsmart recurrence with data-driven precision. Credit available for this activity expires: 04/27/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cracking-code-optimizing-outcomes-all-patients-high-risk-hr-2026a1000crj?ecd=bdc_podcast_libsyn_mscpedu

Do you know when to advance patients with IBS-C from over-the-counter to prescription treatments? Credit available for this activity expires: 04/22/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-otc-cycle-optimizing-prescription-therapy-ibs-c-2026a1000bpz?ecd=bdc_podcast_libsyn_mscpedu

Are you confident in identifying the risk for recurrence in early-stage HR-positive, HER2-negative breast cancer? Credit available for this activity expires: [04/21/27] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/challenging-confines-risk-recurrence-high-risk-hr-her2-early-2026a1000bq3?ecd=bdc_podcast_libsyn_mscpedu

Risk vs Biology: Which carries more weight in the decision to escalate therapy? Credit available for this activity expires: 04/21/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/lessons-real-world-treating-high-risk-hr-her2-breast-cancer-2026a1000bhd?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on the latest clinical developments for steroidal and nonsteroidal mineralocorticoid receptor antagonists (MRAs) in heart failure with preserved ejection fraction (HFpEF)? Credit available for this activity expires: 04/08/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/beyond-headlines-critical-look-mra-evidence-hfpef-2026a1000al7?ecd=bdc_podcast_libsyn_mscpedu

Did you know that antibody-drug conjugates (ADCs) targeting Trop2 have demonstrated significant clinical potential for patients with TNBC? Credit available for this activity expires: 4/8/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/front-antibody-drug-conjugates-shifting-paradigm-metastatic-2026a1000a9z?ecd=bdc_podcast_libsyn_mscpedu

Your patient asks, "Will switching to a biosimilar make my disease worse?" Learn how to confidently address their concerns. Credit available for this activity expires: 4/7/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003282?ecd=bdc_podcast_libsyn_mscpedu

Did you know prior CDK4/6 duration may be prognostic for identifying patients more likely to benefit from single-agent oral SERDs? Credit available for this activity expires: 04/07/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/enhancing-clinical-understanding-oral-serd-based-therapies-2026a1000a46?ecd=bdc_podcast_libsyn_mscpedu

Optimize every trial: Discover how strategic medication selection clarifies the surgical path and improves patient outcomes before intervention. Credit available for this activity expires: 04/02/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/maximizing-therapeutic-efficacy-prior-epilepsy-surgery-2026a10009oz?ecd=bdc_podcast_libsyn_mscpedu

Do you know what to test for in your patients with CRC? Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/expanding-actionability-crucial-biomarkers-your-community-2026a10009al?ecd=bdc_podcast_libsyn_mscped

Do you know the next best steps for a patient with persistent gastroesophageal reflux disease (GERD) symptoms? Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/identifying-suboptimally-managed-erosive-esophagitis-2026a100096o?ecd=bdc_podcast_libsyn_mscped

Get the latest updates on HER2-mutated NSCLC. Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/steps-personalized-and-collaborative-decision-making-her2-2026a10007ur?ecd=bdc_podcast_libsyn_mscped

Are you familiar with the most common treatment-related events of emerging HER2-targeted therapies for gastroesophageal adenocarcinoma (GEA)? Credit available for this activity expires: 3/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/nurse-view-evolution-anti-her2-therapies-gastroesophageal-2026a100096j?ecd=bdc_podcast_libsyn_mscpedu

Learn PFIC genetics, case-based management, and family counseling with Dr Kushner. Credit available for this activity expires: 03/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/progressive-familial-intrahepatic-cholestasis-case-community-2026a100070f?ecd=bdc_podcast_libsyn_mscpedu

A quick take on what's on the horizon for Dravet syndrome treatment Credit available for this activity expires: 03/17/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/rapid-reports-dravet-syndrome-synthesizing-pipeline-2026a10007ux?ecd=bdc_podcast_libsyn_mscpedu

Bronchiectasis affects up to 500,000 Americans and requires a personalized treatment approach to prevent serious complications. Credit available for this activity expires: 03/13/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/demystifying-bronchiectasis-rethinking-standards-care-2026a10006kz?ecd=bdc_podcast_libsyn_mscpedu

Do you know how many different types of anti-HER2 therapies are in clinical trials for gastroesophageal adenocarcinoma (GEA)? Credit available for this activity expires: 02/27/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-ground-gastroesophageal-adenocarcinoma-first-line-2026a10005tj?ecd=bdc_podcast_libsyn_mscpedu

Transforming CLL care: measurable residual disease (MRD) guided stopping, smart triplet selection, and next‑gen Bruton tyrosine kinase (BTKs)—practical insights. Credit available for this activity expires: 02/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-lymphocytic-leukemia-cll-review-combination-2026a10004ku?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date on the management of extensive-stage small cell lung cancer (ES-SCLC)? Credit available for this activity expires: 2/20/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/quick-talk-es-sclc-what-community-clinicians-need-know-now-2026a100055m?ecd=bdc_podcast_libsyn_mscpedu

Clear communication builds trust in biosimilars. Credit available for this activity expires: 2/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1003245?ecd=bdc_podcast_libsyn_mscpedu

Early evidence for CAR T-cell therapy in lupus is compelling. Are you up-to-date? Credit available for this activity expires: 2/9/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/car-t-cells-sle-new-frontier-autoimmunity-2026a10003ow?ecd=bdc_podcast_libsyn_mscpedu

Are you up to date with the latest management for extensive-stage small cell lung cancer? Credit available for this activity expires: 2/11/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/case-case-managing-es-sclc-real-world-through-patient-2026a10003ro?ecd=bdc_podcast_libsyn_mscpedu

How can AID close gaps in T2D care and help you personalize evidence-based AID for real-world practice? Credit available for this activity expires: 1/30/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/utilizing-automated-insulin-delivery-close-gaps-type-2-2026a10002xh?ecd=bdc_podcast_libsyn_mscpedu

Shared decision-making isn't just a buzzword—it's the key to better adherence, fewer exacerbations, and improved quality of life for your patients. Credit available for this activity expires: [01/30/27] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/empowering-choices-moderate-severe-asthma-partnering-2026a10001d4?ecd=bdc_podcast_libsyn_mscpedu

Did you know that as MBC patients get treated with multiple lines of ET, the percentage of patients who develop an ESR1 mutation increases? Credit available for this activity expires: 1/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/current-and-future-oral-serd-strategies-management-er-2026a100022b?ecd=bdc_podcast_libsyn_mscpedu